Department of Dermatology, Allergology, and Phlebology, Bremerhaven Reinkenheide Hospital, Germany.
J Dtsch Dermatol Ges. 2013 Aug;11(8):723-9, 723-30. doi: 10.1111/ddg.12131. Epub 2013 May 29.
Acquired reactive perforating dermatosis is characterized by umbilicated erythematous papules and plaques with firmly adherent crusts. Histopathological examination shows a typical cup-shaped ulceration in the epidermis containing cellular debris and collagen. There is transepidermal elimination of degenerated material with basophilic collagen bundles. The etiology and pathogenesis of acquired reactive perforating dermatosis are unclear. Metabolic disorders and malignancies are associated with this dermatosis. Associated pruritus is regarded as a key pathogenic factor. Constant scratching may cause a repetitive trauma to the skin. This pathogenesis may involve a genetic predisposition. The trauma may lead to degeneration of the collagen bundles. Treatment of acquired reactive perforating dermatosis follows a multimodal approach. Apart from the treating any underlying disease, treatment of pruritus is a major goal. Systemic steroids and retinoids, as well as UVB phototherapy are well-established treatment options. Some patients may also benefit from oral allopurinol.
获得性反应性穿孔性皮病的特征为脐窝状红斑性丘疹和斑块,附有紧密附着的鳞屑。组织病理学检查显示表皮呈典型的杯状溃疡,内含细胞碎片和胶原。存在变性物质经表皮排出,伴有嗜碱性胶原束。获得性反应性穿孔性皮病的病因和发病机制尚不清楚。代谢紊乱和恶性肿瘤与这种皮肤病有关。瘙痒与该疾病相关,被认为是一个关键的致病因素。持续搔抓可能会对皮肤造成反复创伤。这种发病机制可能涉及遗传易感性。创伤可能导致胶原束变性。获得性反应性穿孔性皮病的治疗采用多模式方法。除了治疗任何基础疾病外,治疗瘙痒是一个主要目标。全身类固醇和类维生素 A 以及 UVB 光疗是既定的治疗选择。一些患者也可能受益于口服别嘌呤醇。